TC Biopharm (Holdings) Plc (NASDAQ:TCBP) Short Interest Up 293.3% in October

TC Biopharm (Holdings) Plc (NASDAQ:TCBP) was the target of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 64,900 shares, a growth of 293.3% from the October 15th total of 16,500 shares. Based on an average daily volume of 698,100 shares, the days-to-cover ratio is currently 0.1 days.

TC Biopharm Stock Up 1.9 %

NASDAQ TCBP traded up $0.02 during trading hours on Tuesday, hitting $1.10. The company had a trading volume of 570,807 shares, compared to its average volume of 372,631. TC Biopharm has a fifty-two week low of $1.05 and a fifty-two week high of $138.00. The company has a debt-to-equity ratio of 1.31, a current ratio of 0.88 and a quick ratio of 0.88. The business has a fifty day simple moving average of $4.68 and a 200-day simple moving average of $7.40.

About TC Biopharm

TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers.